Dental News - Implant failure may be related to bisphosphonate use

Dental Tribune International

Fri. 27 April 2012

save

NEW YORK CITY, N.Y., USA: The results of a study conducted at the New York University College of Dentistry seem to confirm the hypothesis that the use of oral bisphosphonate is connected to dental implant failure. In the case-control study, more than 300 female patients with failed dental implants were compared with woman whose implants were still intact.

Clinical evaluations at the Department of Periodontology and Implant Dentistry were conducted between 1997 and late 2004. According to the researchers, the clinical data gathered from these examinations showed that in women whose implants had failed the odds of having taken bisphosphonate orally were almost three times higher. Dental implant failure related to the use of oral bisphosphonate also seemed to be more likely to occur in the maxilla.

Neither the quantity nor the duration of bisphosphonate use was evaluated.

Although the risk of implant failure is low, the researchers concluded that oral bisphosphonate could pose a risk to the success of dental implant therapy and should be prescribed with caution.

Earlier research on the association remains ambiguous, as results from Sweden and Australia have not found increased risks for implant failure when bisphosphonate was taken by patients before or after implant placement. However, the majority of clinical organizations still recommend that long-term users stop taking bisphosphonate before undergoing dental implant procedures to avoid complications.

Bisphosphonate, which is taken orally, is usually prescribed to patients suffering from osteoporosis. It can also be used intravenously as part of secondary bone cancer treatment.

To post a reply please login or register

Implant failure may be related to bisphosphonate use

NEW YORK CITY, N.Y., USA: Results derived from a study conducted at the University of New York College of Dentistry seem to confirm the assumption that the ...

Antidepressants linked to tooth implant failure, new study finds

BUFFALO, N.Y., USA: Antidepressants, commonly used to treat anxiety, pain and other disorders, may play a role in dental implant failure, according to a new...

Study suggests dentists cause implant failure

LOMA LINDA, Calif., USA: The indications and versatility of dental implants have increased, and so have complications. Researchers from the Loma Linda ...

Esthetics, prosthetics, periodontics, implants and bisphosphonates

Controversy involving the oral cavity and the effects of using bisphosphonates is causing an obstacle for dentists to help patients achieve optimal health. ...

AAID to present program on restoratively driven implant failures

CHICAGO, Ill., USA: “The Restoratively Driven Implant Failure: Prevention and Treatment” will be covered in-depth June 7 and 8 at the Central ...

Response to Dental Tribune International article, ‘Study suggests dentists cause implant failure’

A brief news item in the online publication Dental Tribune International, titled “Study suggests dentists cause implant failure,” was based on a...

Osteoporosis and bisphosphonates

If used appropriately, bisphosphonates are a tremendous tool in treating osteoporosis. There is currently a great deal of confusing information over when ...

Implant fracture: A look at the physical mechanisms for failure

The etiology and physical mechanism of fractured dental implants phenomenon have been reviewed and studied at length in recent years.1–8 For the most ...

Extensive study links e-cigarette use with increased risk of heart failure

WASHINGTON, US: In recent years, there has been an increase in studies on vaping and its link to oral and overall health. Adding to existing research, a new...

gIDE to host 4-day implant hands-on workshop

LOS ANGELES, Calif., USA: From July 24 to 27, Global Institute for Dental Education (gIDE) will host its quarterly four-day Advanced Implant Therapy ...

Education

On-demand
webinar

Reaching new levels in bone augmentation using Sculptoss^® Individulized ceramic membrane and GTO^®

Dr. Jonas Anderud Department of Oral and Maxillofacial Surgery, Halmstad, Sweden – Department of Biomaterials, Gothenburg University, Sweden

Dr. Johan Malmström Department of Oral and Maxillofacial Surgery, Halmstad, Sweden – Department of Biomaterials, Gothenburg University, Sweden – Brånemark Clinic Gothenburg, Sweden, Dr. Jonas Anderud Department of Oral and Maxillofacial Surgery, Halmstad, Sweden – Department of Biomaterials, Gothenburg University, Sweden

Watch recording

1CE

Live webinar
Tue. 21 October 2025
7:00 PM EST (New York)